ribociclib and sulforaphane

ribociclib has been researched along with sulforaphane* in 1 studies

Other Studies

1 other study(ies) available for ribociclib and sulforaphane

ArticleYear
Novel cyclin-dependent kinase 9 (CDK9) inhibitor with suppression of cancer stemness activity against non-small-cell lung cancer.
    European journal of medicinal chemistry, 2019, Nov-01, Volume: 181

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cyclin-Dependent Kinase 9; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Isothiocyanates; Lung Neoplasms; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Sulfoxides; Tumor Cells, Cultured

2019